Pine Labs IPO Review: Listed at 14% Premium, Now 29% Below Issue Price — What Went Wrong?
Pine Labs had one of the more intriguing IPO stories of 2025 — it listed at a 14% premium on November 14, 2025, briefly touching ₹284 (a 29% intraday gain), only to slide steadily over the following months to trade around ₹157 as of May 2026 — 29% below the issue price of ₹221.
Investors who applied at ₹221 and held are sitting on a significant notional loss. This review explains exactly what happened, whether the business thesis is intact, and what investors should do now.
Pine Labs IPO — Quick Facts
| Detail | Data |
|---|---|
| IPO Open / Close | Nov 7–11, 2025 |
| Issue Price | ₹221 per share |
| Lot Size | 67 shares |
| Minimum Investment | ₹14,807 |
| Issue Size | ₹3,900 crore |
| Fresh Issue | ₹2,080 crore |
| OFS | ₹1,820 crore |
| Listing Date | November 14, 2025 |
| Listing Price | ₹252 (+14% premium) |
| Intraday High on Listing | ₹284 (+29%) |
| Current Price (May 2026) | ~₹157 |
| 52-Week High | ₹284 |
| 52-Week Low | ₹151 |
| Market Cap | ~₹18,000–23,000 crore |
| Lead Manager | Axis Capital |
| Registrar | KFin Technologies |
Listing Day — A Tale of Two Halves
Pine Labs debuted on November 14, 2025 with strong early momentum. The stock opened at ₹252 (14% above issue price) and surged to a high of ₹284 intraday — a near 29% gain that got investors excited. By close, it settled at ₹252, still a solid debut.
The context mattered: Pine Labs listed the same week as Groww (which surged ~30%) and Lenskart (which disappointed). Pine Labs sat in the middle — decent listing, strong business story, but nagging concerns about losses and valuation. See the full IPO Performance 2025 cohort for context.
About Pine Labs
Founded in 1998, Pine Labs is one of India's oldest and most established fintech companies — though it only recently became publicly listed. The company operates a merchant commerce platform connecting merchants, consumer brands, enterprises, and financial institutions.
Core products:
- Smart POS devices — accept cards, UPI, wallets, EMIs at point of sale
- BNPL/EMI solutions — instant affordability products at checkout
- Prepaid & gift cards — largest player in closed/semi-closed loop gift cards in India
- Merchant financing — short-term working capital loans via bank partnerships
- Cross-border payments — processing for international merchants
Scale:
- 9,88,304 merchants as of June 2025
- 716 consumer brands and enterprises
- 177 financial institutions
- ₹11.42 lakh crore in gross transaction value (GTV) in FY25
- 5.68 billion transactions processed in FY25
- Presence in India, Malaysia, UAE, Singapore, Australia, US, and Africa
Key enterprise clients: Amazon Pay, LG Electronics, Flipkart, Croma, HDFC Bank, Axis Bank, ICICI Bank.
Financial Performance — The Persistent Loss Problem
Pine Labs' financials tell a story of strong top-line growth undermined by persistent losses:
| Metric | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue (₹ Cr) | 1,597 | 1,824 | 2,327 |
| PAT (₹ Cr) | Loss | -342 | -145 |
| Revenue Growth | — | 14% | 28% |
The good news: losses are narrowing sharply — from ₹342 crore in FY24 to ₹145 crore in FY25. Revenue grew 28% in FY25.
Q3 FY26 Results (December 31, 2025)
Pine Labs reported a Q3 FY26 net profit of ₹42 crore — its first profitable quarter in recent memory — versus a loss of ₹57 crore in Q3 FY25. Revenue was ₹744 crore, up 24% YoY. This was genuinely positive.
Yet the stock continued to fall. Why?
Why Pine Labs Stock Fell Despite Good Results
1. Valuation was stretched at IPO. At ₹221, Pine Labs was valued at ~₹25,000 crore — a significant premium for a loss-making company. When markets corrected in early 2026 (Iran-Israel tensions, global uncertainty), high-multiple loss-making stocks were hit hardest.
2. Iran-Israel war impact. Pine Labs fell 18% in March 2026 alone during the peak of the geopolitical tensions. Global risk-off selling disproportionately impacted new-age listed tech stocks.
3. Negative cash flows. Despite Q3 profitability, the company had negative operating cash flows of ₹281 crore in H1 FY26. Cash-burning companies face extra scrutiny in risk-off markets.
4. Audit qualifications. Pine Labs' auditor reports contained "certain remarks and modifications including adverse opinions" for FY23, FY24, and FY25. This overhang creates institutional investor caution.
5. Customer concentration. Top 5 customers = 21% of revenue; top 1 customer = 8.24% of revenue. Not extreme but notable for a payments platform.
Use our IPO listing calculator to map your buy price against current CMP for an exact P&L picture.
Post-Listing Developments
- Feb 2026: Q3 FY26 results — first profitable quarter. Stock failed to sustain gains.
- Apr 25, 2026: Pine Labs approved acquisition of Shopflo Technologies for up to ₹88 crore — a checkout optimization startup. Adds D2C/e-commerce checkout capabilities.
- May 2026: Board meeting called for May 25 to approve audited FY26 annual results. Q4 FY26 earnings are the next major catalyst.
- Analyst consensus: Average 12-month price target of ~₹248, representing ~58% upside from current levels. 2 Buy ratings, 1 Sell rating as of May 2026.
Investors looking for the next Fintech IPOs 2026 should learn from Pine Labs' valuation lessons.
Should You Buy, Hold or Sell Pine Labs?
If you got IPO allotment (holding since ₹221): You're down ~29%. The business has shown one profitable quarter (Q3 FY26), but cash flows remain negative and the full-year FY26 results (due May 25 board meeting) will be the real verdict. Hold through the results before deciding — selling now crystallises a 29% loss at what may be the bottom.
If you bought post-listing (between ₹250-280): You're significantly down. This is a patience play — analyst targets suggest 50%+ upside from current levels if the company turns fully profitable in FY26. However, given audit qualifications and cash flow concerns, position sizing is key.
If you're considering buying at ₹157: Analyst average target of ₹248 suggests meaningful upside. The Shopflo acquisition signals product expansion intent. The risk is FY26 results showing renewed losses or continued cash burn. If you're comfortable with a 12–24 month holding period for a fintech recovery play, current levels could be a reasonable entry. Start with a small position and wait for Q4 FY26 results clarity.
Not investment advice. Please consult a SEBI-registered advisor.
Pine Labs vs Peers — Valuation Context
| Company | Market Cap | Revenue | P/S Ratio |
|---|---|---|---|
| Pine Labs | ~₹18,000 Cr | ₹2,327 Cr | ~7.7x |
| PayTM | ~₹42,000 Cr | ₹9,700 Cr | ~4.3x |
| One97 Comms | Large cap | Large | Higher |
Pine Labs still trades at a premium to profitability peers on price-to-sales. The re-rating opportunity exists if the company delivers 2–3 consecutive profitable quarters.
Key Risks
Profitability not yet sustained: One profitable quarter does not make a trend. If Q4 FY26 shows a return to losses, the stock will sell off sharply.
Audit qualifications: Three consecutive years of auditor remarks is an institutional investor red flag. Watch for the FY26 audit outcome.
Competition: Razorpay, PayTM, PhonePe, and global POS players (Square, Worldline) all compete in segments Pine Labs serves.
Cash flow: Negative operating cash flows even in a profitable quarter is a structural concern that needs to be addressed.
Frequently Asked Questions
What was Pine Labs IPO listing price? Pine Labs listed at ₹252 on November 14, 2025 — a 14% premium to the issue price of ₹221. The stock hit an intraday high of ₹284.
What is Pine Labs share price today? As of May 2026, Pine Labs (NSE: PINELABS) is trading around ₹157 — approximately 29% below the IPO issue price of ₹221.
Why did Pine Labs share price fall after IPO? Multiple factors: stretched IPO valuation, geopolitical selloff in March 2026, persistent negative cash flows, and audit qualification overhang despite improving quarterly results.
Is Pine Labs profitable? Pine Labs reported its first profitable quarter in Q3 FY26 (Oct–Dec 2025) with ₹42 crore PAT. Annual FY25 loss was ₹145 crore, down from ₹342 crore in FY24.
What does Pine Labs do? Pine Labs provides a full-stack merchant commerce platform — POS terminals, BNPL/EMI solutions, prepaid gift cards, merchant financing, and cross-border payments to 9.88 lakh merchants across India and Southeast Asia.
Should I buy Pine Labs stock now? Analyst average target is ~₹248 (vs current ~₹157), implying ~58% upside. However, wait for Q4 FY26 results (board meeting May 25, 2026) before investing. Not investment advice.
Track Pine Labs Live
- Current share price: NSE: PINELABS (live ticker shown above)
- 52-week range: ₹151 – ₹284
- Q4 FY26 results: Board meeting May 25, 2026
- Compare IPO performance: IPO Performance 2025
- Calculate your loss/gain: IPO listing calculator
- Track grey market premium: GMP tracker
- See Fintech IPOs 2026 pipeline
Last updated: May 8, 2026